Call — Innovations in Biotherapies & Bioproduction (Appel à projets)
Funds French biotherapy and bioproduction innovation with blended grants and recoverable advances.
Innovations en biothérapies et bioproduction is a France 2030 call run by Bpifrance for the national acceleration strategy on biotherapies and bioproduction. It sits at the intersection of therapeutic development, enabling tools, and industrial-scale production. The program is active through September 2026. The call funds three tracks: biotherapies for human or animal health when human-health impact is envisaged, R&D tools and stratification methods for biotherapy development, and new bioproduction processes, equipment, tools, and optimization systems. Aid is delivered as a blended grant and recoverable advance, and the current cycle runs through two relays, one in March 2026 and a final one in September 2026. The best fit is a team that can place its work inside a specific biotherapy or bioproduction chain and show why the project matters for industrial readiness. Applicants should read it as a strategic route for platform or process development rather than a simple cash grant.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.